Thomas J. Anderson

Thomas J. Anderson

Auto-generated profile, based on publicly available information

Thomas J. Anderson

Edmonton, Alberta

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2009 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
MLM. Lowrie
M. Lowrie
JPJ. Penderis
J. Penderis
MMM. McLaughlin
M. McLaughlin
PEP.D. Eckersall
P.D. Eckersall
TAT.J. Anderson
T.J. Anderson
Background: Previous multidrug studies have identified the value of prednisolone in treating steroid responsive meningitis‐arteritis (SRMA) and the potential value of acute phase proteins (APPs) and immunoglobulin A (IgA) in diagnosis and monitoring. Hypothesis: (1) Prednisolone monotherapy is a successful immunosuppressive modality in the treatment of SRMA; (2) protein markers are useful in identifying the potential for relapse. Animals: Twenty client‐owned dogs with SRMA presented to the University of Glasgow Small Animal Hospital between May 2006 and May 2008. Methods: A prospective, observational study: CBC, biochemistry, and cerebrospinal fluid (CSF) analyses were performed. C‐reactive protein (CRP), serum amyloid‐A, α‐1‐acid glycoprotein, and haptoglobin (Hp) were assessed in the serum. IgA concentrations were determined in the serum and CSF. Results: Clinical resolution of SRMA was achieved in all 20 dogs. Serum CRP concentration remained increased at remission in 16/20 dogs whereas CSF cytology was within normal limits in 20/20 dogs. Serum APPs decreased significantly on treatment (P < .05) except Hp, which remained unaltered. Serum and CSF IgA concentrations remained increased for the duration of treatment. Conclusions and Clinical Importance: The prednisolone regimen presented was successful in treating SRMA without the need for additional drugs. Serum APPs are of use in the diagnosis and management of SRMA, particularly in relation to identifying relapse. Serum and CSF IgA concentrations remain increased throughout disease, aiding in diagnosis but not contributing to the management of SRMA.

1 October 2009 in The Veterinary Journal
Verified
Journal Article
Closed access
MLM. Lowrie
M. Lowrie
JPJ. Penderis
J. Penderis
PEP.D. Eckersall
P.D. Eckersall
MMM. McLaughlin
M. McLaughlin
DMD. Mellor
D. Mellor
TAT.J. Anderson
T.J. Anderson

28 November 2006 in Glia
Verified
Journal Article
Closed access
PDF file
SKSaadia A. Karim
Saadia A. Karim
JBJennifer A. Barrie
Jennifer A. Barrie
MMMailis C. McCulloch
Mailis C. McCulloch
PMPaul Montague
Paul Montague
JEJulia Edgar
Julia Edgar
MMMark Mclaughlin
Mark Mclaughlin

24 March 2011 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
TRTorsten Ruest
Torsten Ruest
WHWilliam M. Holmes
William M. Holmes
JBJennifer A. Barrie
Jennifer A. Barrie
IGIan R. Griffiths
Ian R. Griffiths
TAThomas J. Anderson
Thomas J. Anderson
JEJulia Edgar
Julia Edgar

13 July 2010 in Glia
Verified
Journal Article
Closed access
PDF file
SKSaadia A. Karim
Saadia A. Karim
JBJennifer A. Barrie
Jennifer A. Barrie
MMMailis C. Mcculloch
Mailis C. Mcculloch
PMPaul Montague
Paul Montague
JEJulia Edgar
Julia Edgar
MMMark McLaughlin
Mark McLaughlin

1 August 1993 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JDJ. M. Dixon
J. M. Dixon
OSO. Ravi Sekar
O. Ravi Sekar
JWJ. Walsh
J. Walsh
DPD. Paterson
D. Paterson
TAT. J. Anderson
T. J. Anderson